Asset Details
Do you wish to reserve the book?
Oseltamivir Becomes Plentiful: But Still Not Cheap
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oseltamivir Becomes Plentiful: But Still Not Cheap
Do you wish to request the book?
Oseltamivir Becomes Plentiful: But Still Not Cheap
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Oseltamivir Becomes Plentiful: But Still Not Cheap
2006
Overview
The shortage of oseltamivir may soon be a thing of the past. But whether the drug will become cheap enough for developing countries and how well it will work against a pandemic remain to be seen.
Publisher
American Association for the Advancement of Science,The American Association for the Advancement of Science
Subject
Acetamides - administration & dosage
/ Acetamides - chemical synthesis
/ Acetamides - supply & distribution
/ Animals
/ Antiviral Agents - administration & dosage
/ Antiviral Agents - chemical synthesis
/ Antiviral Agents - economics
/ Antiviral Agents - supply & distribution
/ Drugs, Generic - chemical synthesis
/ Drugs, Generic - supply & distribution
/ H5N1 subtype influenza A virus
/ Humans
/ Influenza A Virus, H5N1 Subtype - drug effects
/ Influenza, Human - drug therapy
/ Influenza, Human - prevention & control
/ LDCs
/ News
